Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 33 filings.
24 Aug 2026 1 filing
AGM proceedings and governance actions
AGM held Aug 20, 2026 via VC/OAVM; 57 members attended.
Remote e-voting Aug 17-19; record date Aug 13; delay in filing acknowledged; clarification issued Aug 24, 2026.
Dividend on equity shares for year ended Mar 31, 2026 declared.
Ordinary business: adopt Audited Balance Sheet and P&L with reports.
Appointment of Arvind Dadha as director; retires by rotation.
Re-appointment of Shashi Ashok Bekal as Independent Director.
Re-appointment of Kantikumar Dadha as Chairman and Whole-time Director; remuneration fixed.
Re-appointment of Arvind Dadha as Managing Director; remuneration fixed.
Re-appointment of Ashish Dadha as Whole Time Director and CFO; remuneration fixed.
All resolutions passed with requisite majority; AGM duration 3:00 PM to 4:10 PM.
21 Aug 2026 3 filings
Bekal Independent Director reappointment
Reappointed Shashi Ashok Bekal as Independent Director for five years from June 21, 2026.
Relation: Bekal not related to promoters or directors.
Kantikumar Dadha reappointment as Chairman & WTD
Reappointment of Kantikumar Dadha as Chairman and Whole-Time Director from Oct 01, 2026 for three years.
Relations: Arvind is Kantikumar Dadha's son; Ashish is Kantikumar Dadha's son.
Arvind Dadha reappointment as Managing Director
Reappointment of Arvind Dadha as Managing Director from Oct 01, 2026 for three years.
Relation: Arvind is Kantikumar Dadha's son.
Ashish Dadha reappointment as WTD & CFO
Reappointment of Ashish Dadha as Whole-Time Director cum CFO from Apr 01, 2027 for three years.
Relations: Father of Kantikumar Dadha; Brother of Arvind Dadha.
AGM details
36th AGM held Aug 20, 2026 at 3:00 PM IST via VC/OAVM.
57 members attended.
Remote e-voting: Aug 17–19, 2026; record date Aug 13, 2026.
Meeting duration: 3:00 PM to 4:10 PM IST.
Ordinary business
Adoption of Audited Balance Sheet, P&L, and reports — Passed.
Dividend declaration on equity shares for the year ended Mar 31, 2026 — Passed.
Director matters
Arvind Dadha re-appointed by rotation.
Shashi Ashok Bekal re-appointed as Independent Director (Special Resolution).
Kantikumar Dadha re-appointed as Chairman and Whole-time Director; remuneration fixed (Special Resolution).
Arvind Dadha re-appointed as Managing Director; remuneration fixed (Special Resolution).
Ashish Dadha re-appointed as Whole Time Director cum CFO; remuneration fixed (Special Resolution).
Voting results
All resolutions passed with requisite majority.
19 Aug 2026 2 filings
Financial Performance
Q1 FY27 revenue from operations: INR85.21 crores; YoY growth ~23%.
EBITDA: INR8.64 crores; EBITDA margin 10.14% (up from 7.35%).
Net profit: INR5.14 crores; net margin 6.03% (vs 4.2%).
Two-year trend: revenue 230 crores to 281 crores; EBITDA 16.9 to 22.84 crores.
Export revenue on the rise; current export level around INR280 crores.
Top 10 customers contribute about 60%–65% of revenue.
Lab-grown jewelry revenue share currently less than 5%–7%.
New Mumbai facility capacity around 125–150 kg/year.
Facility uplift increases total capacity by about 50%–60%.
Capital raised via convertible warrants INR27 crores to support expansion.
Domestic Expansion and Capex
Andheri facility: 5,360 sq ft; 125–150 kg/year capacity.
Capacity uplift: 50%–60% added.
Facility to diversify revenue into domestic market and B2C, including lab-grown.
New funding via convertible warrants: INR27 crores for expansion and working capital.
Strategy and Guidance
Current year growth target around 15% to 20%, export-led.
By 2030 domestic revenue ~50% of total.
Lab-grown to be a significant domestic contributor; B2C launch planned around Diwali.
US lab-grown performance expected to improve after tariff headwinds; better growth this year.
Incremental capacity revenue potential INR250–300 crores.
Total revenue target around INR550–600 crores by 2030 (based on current export ~INR280 crores).
Q&A Highlights
Domestic expansion strategy: supply to major Indian retailers; pursue B2C lab-grown.
Lab-grown competition: no clear Indian peer yet; many players entering market.
Hedging: gold natural hedge; diamonds forward contracts for receivables 4–6 months.
Incremental capacity revenue potential INR250–300 crores.
Top 10 customers contribute ~60–65% of revenue.
Lab-grown share currently less than 5%–7%; US accounts for larger share.
Export base heavy in Middle East; USA share below 10% after tariff issues; improving.
New Mumbai facility ramp: current year revenue INR15–20 crores; peak INR250 crores in 3 years.
B2C launch targeted around Diwali; calendar year 2026.
Long-term vision: 50% domestic by 2030; growth from domestic and exports.
Balance Sheet and Cash Flows
Capital raised INR27 crores via convertible warrants; used for expansion and working capital.
Facility expansion financed to support domestic growth.
Risks and Watchpoints
Tariffs in the US impacted earlier; improved this year.
Hormuz disruption affected shipping for about a month; now normal.
Inventory levels: export ~10–11x; domestic similar; managing working-capital cycle.
14 Aug 2026 1 filing
Meeting Details
Date and time: 13-Aug-2026 at 4:00 PM IST.
Type and mode: investor/analyst call; virtual.
Event/organiser: investor call for Golkunda Diamonds & Jewellery Limited.
Purpose: discuss quarterly results for June 30, 2026, plus growth plans.
Key participants: CFO, Head of Investor Relations, Company Secretary.
Recording: audio call recording available.
13 Aug 2026 1 filing
Business overview
Q1 FY27 revenue from operations ₹8,521.49 Lakhs; total revenue ₹8,540.87 Lakhs.
Diversified exports to USA, Europe, Middle East; new Mumbai unit increases capacity.
New manufacturing unit enables cross-spectrum production: diamonds, gold, gemstone, jadau, LGD.
Key operational highlights
New Mumbai facility adds ~125-150 kg p.a., lifting total capacity 50–60%.
Domestic LGD and gold jewelry manufacturing expansion to meet rising Indian retailer demand.
Export base remains diversified; 40+ years market presence aids risk mitigation.
Financial performance
Q1 FY27 revenue from operations ₹8,521.49 Lakhs; total revenue ₹8,540.87 Lakhs; YoY +22.7%.
EBITDA ₹864.12 Lakhs; margin 10.14%; Net profit ₹514.03 Lakhs; margin 6.03%.
FY26 revenue ₹28,150.15 Lakhs; PAT ₹1,369.42 Lakhs; EBITDA ₹2,284.29 Lakhs; EBITDA margin 8.11%.
Q1 FY27 diluted EPS ₹7.32.
Capital structure & liquidity
FY26 equity ₹8,023.83 Lakhs; total borrowings ₹3,655.08 (current ₹2,766.08, non-current ₹889.00).
Cash and cash equivalents end FY26 ₹319.78 Lakhs.
Net cash from operating activities FY26 ₹961.32 Lakhs.
Strategic priorities & outlook
Expansion into lab-grown diamond and gold jewelry manufacturing to meet domestic demand.
Domestic market expansion and pan-India retail partnerships.
Leverage export base with Mumbai unit for end-to-end production.
Risks & mitigation
No explicit material risks disclosed in this investor presentation excerpt.
Governance & leadership
Chairman & WTD: Kantikumar Dadha; MD: Arvind Dadha; CFO/Director: Ashish Dadha.
8 Aug 2026 1 filing
Financial and operational highlights
Total revenue: ₹85.21 crore, up 22.72% YoY.
EBITDA: ₹8.64 crore, up 69.32% YoY.
EBITDA margin: 10.12% vs 7.35% prior year, +277 bps.
PAT: ₹5.14 crore; PAT margin: 6.02% vs 4.52% prior year.
EPS (diluted): ₹7.32 vs ₹4.50 prior year.
New domestic manufacturing facility in Mumbai now operational; capacity 125-150 kg per annum.
Focus on lab-grown diamond segment; planned entry into B2C retail.